𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Distinctive clinicopathological features of Ki-ras mutated colorectal cancers

✍ Scribed by Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Chone Chen; Tzu-Chen Lin; Anna Fen-Yau Li

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
237 KB
Volume
94
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ki-ras MUTATIONS IN ADENOMAS: A CHARACTE
Ki-ras MUTATIONS IN ADENOMAS: A CHARACTERISTIC OF CANCER-BEARING COLORECTAL MUCOSA
✍ MORRIS, ROBERT G.; CURTIS, LUCY J.; ROMANOWSKI, PIOTR; HARDCASTLE, JACK D.; JENK πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 652 KB

Activating mutations in the Ki-ras2 oncogene are frequently observed in sporadic colorectal adenomas and their incidence is reported to rise in large and tubulovillous adenomas to values close to those in carcinomas. This study shows that this property is a feature of adenomas growing in large bowel

Clinicopathological and protein characte
Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis
✍ Inti Zlobec; Michel P. Bihl; Heike Schwarb; Luigi Terracciano; Alessandro Lugli πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 310 KB πŸ‘ 1 views

## Abstract Recent evidence highlights the potential prognostic and predictive value of __BRAF__ and __K‐RAS__ gene alterations in patients with colorectal cancer. However, a comprehensive evaluation of __BRAF__ and __K‐RAS__ mutations and their specific clinicopathological features, histomorpholog

Suppression of Ki-ras p21 levels leading
Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation
✍ Kazunori Aoki; Teruhiko Yoshida; Nobuyuki Matsumoto; Hisamitsu Ide; Takashi Sugi πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 168 KB πŸ‘ 1 views

Ki-ras point mutation characteristically occurs frequently in human pancreatic cancer. To clarify the effect of antisense Ki-ras RNA on various pancreatic cancer cell lines, a plasmid expressing an antisense Ki-ras gene fragment (AS-K-ras-LNSX) was transduced into seven human pancreatic cancer cell